NASDAQ NMS - GLOBAL MARKET · ALEC
-11.48% · -$0.2100 · Vol 589.3K
Market closed · last close 4:00 PM ET · price as of 19:38:28 ET
Alector Inc

Alector Inc

Biotechnology
$1.62
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ALEC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ALEC are being assembled.
About Alector Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2019
Employees
103
Country
US

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.83
Day high
$1.86
Day low
$1.60
Previous close
$1.83
52W high
$2.12
-23.40% from high
52W low
$1.49
21% of range
Market cap
$203.2M
EPS
$-1.2600
Shares out
111M
Volume
589.3K
VWAP
$1.68
Price history computed in-house
1W
-20.39%
1M
+5.54%
SMA 50 $1.77 · below
SMA 200 $1.77 · below
52W position 21%
Veridion warehouse edge

Warehouse intelligence for ALEC.

Veridion Score
18
0: 281: 262: 303: 204: 665: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ALEC insider activity

Alector Inc

Score
Coverage building
Pressure
Net selling
Filings
21
Buys / sells
0 / 21
Net value
-$1.0M
Insiders
5
Named filers
WG
Wong-Sarad Grace
Insider
Leadership
RA
Rosenthal Arnon
Insider
Leadership
BL
Berkley Neil Lindsay
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$1.0M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-032026-06-03Wong-Sarad GraceInsidersell$1.883,47595,461$7KSEC Form 4
2026-06-032026-06-02Rosenthal ArnonInsidersell$1.9787,2162,367,206$172KSEC Form 4
2026-06-032026-06-02Wong-Sarad GraceInsidersell$1.975,70998,936$11KSEC Form 4
2026-06-032026-06-02Berkley Neil LindsayInsidersell$1.9719,360379,900$38KSEC Form 4
2026-04-172026-04-16Wong-Sarad GraceInsidersell$2.651,820104,645$5KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 16 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ALEC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALEC in this window.
Lobbying spend

ALEC lobbying filings, year to date.

Registered lobbying filings matched to Alector Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALEC in this window.
Latest news · ALEC
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ALEC.
Options
Sovereign unlock shows live options positioning for ALEC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.